Cyteir Therapeutics Inc (CYT) is lower by Tuesday morning, with the stock decreasing -0.66% in pre-market trading to 3.01. CYT's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 94% of stocks. Cyteir Therapeutics Inc has fallen 1.30% over the past month, closing at $3.01 on October 17. During this period of time, the stock fell as low as $2.98 and as high as $3.08. CYT has an average analyst recommendation of Sell. The company has an average price target of $3.00.
CYT has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CYT!